The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa (Q37067896)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on February 1970

Language	Label	Description	Also known as
English	The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa	scientific article published on February 1970

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

cerebrospinal fluid

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

parkinsonian syndrome

1 reference

based on heuristic

inferred from title

1

object named as

G Curzon

1 reference

Europe PubMed Central

18 August 2017

PMC publication ID

Richard B. Godwin-Austen

2

object named as

R B Godwin-Austen

1 reference

Europe PubMed Central

18 August 2017

PMC publication ID

3

object named as

E B Tomlinson

1 reference

Europe PubMed Central

18 August 2017

PMC publication ID

B D Kantamaneni

4

object named as

B D Kantamaneni

1 reference

Europe PubMed Central

18 August 2017

PMC publication ID

language of work or name

0 references

publication date

1 February 1970

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

33

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1-6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

29 September 2017

The brain-stem lesions in Parkinsonism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

29 September 2017

The effect of tropolone on the formation of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of the mouse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

29 September 2017

DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

27 June 2018

Acceleration of the cerebral dopamine turnover by chlorpromazine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

27 June 2018

Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

27 June 2018

L-dopa in postencephalitic parkinsonism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

27 June 2018

Modification of Parkinsonism--chronic treatment with L-dopa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

27 June 2018

INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

4 September 2018

Chemical and physiological changes produced by arterial infusion of dihydroxyphenylalanine into one cerebral hemisphere of the cat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

4 September 2018

On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

4 September 2018

Microanalytical procedures for fluorometric assay of brain DOPA-5HTP decarboxylase, norepinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

4 September 2018

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

4 September 2018

Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

4 September 2018

L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism

1 reference

https://pubmed.ncbi.nlm.nih.gov/5418176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease.]

1 reference

https://pubmed.ncbi.nlm.nih.gov/5418176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased homovanillic acid concentration in the brain in parkinsonian subjects as an expression of a disorder of central dopamine metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/5418176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/5418176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of L-dopa in Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/5418176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.33.1.1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Semantic Scholar paper ID

ff529e39c8853d4b23bfb6eaeef443c98090073c

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37067896&oldid=2220116705"